Skip to main content

Open Access 11.12.2023 | Original Article

Breath-Hold-Triggered BOLD fMRI in Drug-Resistant Nonlesional Focal Epilepsy—A Pilot Study

verfasst von: Christian M. Boßelmann, Josua Kegele, Leonie Zerweck, Uwe Klose, Silke Ethofer, Constantin Roder, Alexander M. Grimm, Till-Karsten Hauser

Erschienen in: Clinical Neuroradiology

Abstract

Purpose

Individuals with drug-resistant epilepsy may benefit from epilepsy surgery. In nonlesional cases, where no epileptogenic lesion can be detected on structural magnetic resonance imaging, multimodal neuroimaging studies are required. Breath-hold-triggered BOLD fMRI (bh-fMRI) was developed to measure cerebrovascular reactivity in stroke or angiopathy and highlights regional network dysfunction by visualizing focal impaired flow increase after vasodilatory stimulus. This regional dysfunction may correlate with the epileptogenic zone. In this prospective single-center single-blind pilot study, we aimed to establish the feasibility and safety of bh-fMRI in individuals with drug-resistant non-lesional focal epilepsy undergoing presurgical evaluation.

Methods

In this prospective study, 10 consecutive individuals undergoing presurgical evaluation for drug-resistant focal epilepsy were recruited after case review at a multidisciplinary patient management conference. Electroclinical findings and results of other neuroimaging were used to establish the epileptogenic zone hypothesis. To calculate significant differences in cerebrovascular reactivity in comparison to the normal population, bh-fMRIs of 16 healthy volunteers were analyzed. The relative flow change of each volume of interest (VOI) of the atlas was then calculated compared to the flow change of the whole brain resulting in an atlas of normal cerebral reactivity. Consequently, the mean flow change of every VOI of each patient was tested against the healthy volunteers group. Areas with significant impairment of cerebrovascular reactivity had decreased flow change and were compared to the epileptogenic zone localization hypothesis in a single-blind design.

Results

Acquisition of bh-fMRI was feasible in 9/10 cases, with one patient excluded due to noncompliance with breathing maneuvers. No adverse events were observed, and breath-hold for intermittent hypercapnia was well tolerated. On blinded review, we observed full or partial concordance of the local network dysfunction seen on bh-fMRI with the electroclinical hypothesis in 6/9 cases, including cases with extratemporal lobe epilepsy and those with nonlocalizing 18F-fluorodeoxyglucose positron emission tomography (FDG-PET).

Conclusion

This represents the first report of bh-fMRI in individuals with epilepsy undergoing presurgical evaluation. We found bh-fMRI to be feasible and safe, with a promising agreement to electroclinical findings. Thus, bh-fMRI may represent a potential modality in the presurgical evaluation of epilepsy. Further studies are needed to establish clinical utility.
Hinweise

Supplementary Information

The online version of this article (https://​doi.​org/​10.​1007/​s00062-023-01363-2) contains supplementary material, which is available to authorized users.

Data and/or Code Availability

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Epilepsy affects 1–2% of people worldwide and a third of all individuals with focal epilepsy will fail to achieve seizure freedom despite treatment with two adequate and well-tolerated antiseizure medications (ASM) [1, 2]. These individuals with drug-resistant epilepsy (DRE) suffer from psychiatric and somatic comorbidities, lower economic status, social stigma, and increased all-cause mortality including sudden unexpected death in epilepsy [35]. Epilepsy surgery may be a safe and effective treatment option that is associated with lower morbidity, lower mortality, and a higher rate of seizure freedom when compared to prolonged medical treatment [6, 7]. The likelihood of a favorable outcome of surgical treatment is substantially higher if an epileptogenic lesion can be identified during presurgical evaluation [8]. The method of choice is structural magnetic resonance imaging (MRI) according to an epilepsy MRI protocol (HARNESS-MRI) [9, 10]. Even with advanced imaging techniques and postprocessing, MRI fails to detect a lesion in up to a third of individuals with temporal lobe epilepsy [11]. These individuals with nonlesional focal epilepsy (NLFE) may require additional testing to more clearly delineate the epileptogenic zone, including 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) or single-photon emission computed tomography (SPECT) [12].
Another imaging modality has been developed to noninvasively study cerebrovascular hemodynamics and reserve capacity in patients with ischemic stroke or moyamoya angiopathy [1315]. Breath-hold-triggered BOLD fMRI (bh-fMRI) measures cerebrovascular reactivity, i.e., the relative change in cerebral perfusion in response to a vasodilatory stimulus [15]. Breathing maneuvers by the patient represent such a hypercapnic stimulus causing vasodilatation and thus increased cerebral blood flow. When oxygen utilization stays constant, the ratio of oxyhemoglobin to deoxyhemoglobin increases. This in turn leads to an increase in T2* BOLD signal. This method is safe, non-invasive, and does not require exposure to radiation or radionuclides. It is also cost-effective and can be acquired with few additional sequences, without the need for any additional equipment [13].
Changes in cerebral hemodynamics and reserve capacity in individuals with epilepsy are currently not well understood. Previously, Bek et al. evaluated the breath-holding index as a measure of cerebrovascular reactivity with transcranial Doppler ultrasonography (TCD) in 20 individuals with epilepsy. They noted an increased breath-holding index in the group with epilepsy when compared to healthy controls and speculated that this may be the result of an adaptive mechanism against hypoxic challenges in seizure apnea [16]. Contrarily, Chen et al. reported 81 individuals with epilepsy in which they assessed cerebral autoregulation by TCD during breath-hold maneuvers, among others. They noted a decrease in breath-holding index, autoregulation, and cerebrovascular resistance, each correlating with several measures of autonomic function, suggesting that autonomic dysfunction in individuals with epilepsy may contribute to dysregulation of cerebral blood flow [17]. More generally, Dono et al. noted that autonomic function in temporal lobe epilepsy, the most common type of focal epilepsy, may contain lateralizing information valuable for presurgical evaluation. In their study, left temporal lobe epilepsy was associated with increased cardiac vagal tone [18].
Thus, autonomic changes in cerebral hemodynamics have been proposed to highlight areas of local network dysfunction which may potentially correlate with the localization of the epileptogenic zone. Small case series of contrast-enhanced diffusion and perfusion MRI or oxygen-enhanced MRI have indeed shown potential benefit in lateralization and localization [19, 20]. Likewise, arterial-spin labeling perfusion imaging (ASL) has been demonstrated to generate findings that are concordant with PET and electroencephalography (EEG) [21, 22]. Although ASL is able to show changes in cerebral perfusion, cerebrovascular reactivity is commonly assessed by administration of a vasodilatory drug (e.g., acetazolamide) between measurements [23]. By using bh-fMRI, cerebrovascular reactivity can reliably be estimated using just a repeated short breath-hold period during a standard BOLD fMRI measurement [14]. In this prospective single-center single-blind pilot study, we aimed to establish the feasibility and safety of bh-fMRI in individuals with drug-resistant nonlesional focal epilepsy undergoing presurgical evaluation and healthy controls.

Methods

Cohort

This single-center study was conducted at the Department of Neurology and Epileptology, University Hospital Tübingen, between November 2021 and May 2022. Participants were prospectively and consecutively recruited from all individuals undergoing presurgical evaluation. Inclusion criteria were: i) age 18–70 years; ii) diagnosis of drug-resistant focal epilepsy according to the criteria of the Task Force of the International League Against Epilepsy (ILAE) Commission on Therapeutic Strategies [1]; iii) nonlesional focal epilepsy, i.e., prior structural imaging according to the HARNESS-MRI protocol that failed to detect an epileptogenic lesion and iv) case review at the interdisciplinary epilepsy surgery conference. Exclusion criteria were: i) inability to give informed consent; ii) any history of psychogenic nonepileptic seizures; iii) any history of primary generalized onset seizures; iv) pregnancy; v) any absolute or relative contraindications against MRI, including but not limited to presence of implanted devices, prostheses, surgical clips, wires, sutures or mesh, dental implants or retainers, or any foreign metallic body and vi) any condition that may prevent the participant from lying down for an extended period (e.g., pain, claustrophobia or pulmonary disease). Overall, 24 individuals were screened, and 10 individuals agreed to participate in the study.

Electroclinical Hypothesis

Electroclinical data were obtained from epilepsy surgery conference reports and medical chart review. All available data were considered within the multidimensional concept of the epileptogenic zone by Lüders et al. [24]. The irritative zone, i.e., the area of cortex that generates interictal spikes, and the seizure-onset zone, i.e., the area of the cortex that initiates clinical seizures, were respectively defined with routine scalp EEG, video EEG, magnetoencephalography (MEG) or stereo electroencephalography when available. The symptomatogenic zone, i.e., the area of cortex that produces the initial ictal signs, was defined by consideration of lateralizing and localizing seizure semiology provided by the patient history or video EEG observation. The functional deficit zone, i.e., the cortical area that is functioning abnormally in the interictal period, was defined by neurological examination, neuropsychological examination, and functional imaging (18-FDG-PET-MRI) where available. Interictal SPECT was not done. Proposed localization of the epileptogenic zone was determined via blinded case review by an epileptologist who was not provided with the results of bh-fMRI before the localization hypothesis was established. The epileptogenic zone was defined as “area of cortex that is necessary and sufficient for initiating seizures and whose removal (or disconnection) is necessary for complete abolition of seizures” [25], with an additional emphasis on ictal EEG and especially confirmation by stereo electroencephalography if available [26]. This theoretical cortical zone is a primarily surgically motivated abstract concept that cannot be directly visualized on imaging, including bh-fMRI, but which represents the integrated diagnostic outcome of the presurgical evaluation. Thus, any correlation between focal abnormalities seen on bh-fMRI and this localization hypothesis would be potentially useful in a clinical setting.

Neuroimaging and Analysis

All imaging data were acquired on a 3 T Scanner (Magnetom Prisma fit, Siemens, Erlangen, Germany) using a standard 20 channel head coil. The imaging protocol consisted of a T2* weighted EPI sequence with the following imaging parameters: TR 3000 ms, TE 36 ms, matrix 96 * 96, slice thickness 3 mm, 40 slices, FOV 245 × 245 mm, voxel size 2.6 × 2.6 × 3 mm. The paradigm consisted of 7 cycles of 9 s breath-hold in expiration followed by 60 s of normal breathing, starting with 1min of normal breathing. During the fMRI acquisition, compliance was checked via monitoring breathing using the built-in physiological monitoring capability of the scanner. The instructions were presented visually using a wall-mounted display and a coil-mounted mirror. A test run, where the participant was placed on the scanner table but outside of the gantry, preceded the final measurement to ensure that the participant understood the visually presented task. All instructions were scanner-triggered and software-generated (Presentation 20.1, Neurobehavioral Systems, Berkeley, CA, USA).
The MRI data processing was performed on a dedicated workstation. Data were preprocessed using the software package statistical parametric mapping SPM12 (The Wellcome Dept. of Imaging Neuroscience, London, UK; www.​fil.​ion.​ucl.​ac.​uk/​spm). After conversion into nifti file format, slice timing correction was applied to the functional data to compensate for differences in image acquisition times. The data were then realigned to remove effects caused by patient movements. After unwarping to remove geometric distortions created in regions of tissue-air interface, the functional data were co-registered with the anatomic T1 3D dataset. The data were spatially normalized to the standard Montreal Neuroimaging Institute (MNI) template, and all data were written in MNI space for subsequent evaluation.
Further analysis was done by a custom script programmed in MATLAB R2021a (The MathWorks Inc, Natick, MA, USA; http://​www.​mathworks.​com). To improve signal quality and reduce noise, the signal was averaged using 116 volumes of interest provided by the automatic anatomic labeling atlas AAL 1 [27]. After detrending to remove signal drift during the measurement, the signal of each breath-hold period was averaged resulting in on signal time curve per volume of interest (VOI). Breath-hold periods were excluded if the cerebellar signal curve, which is assumed to be independent of supratentorial pathology [15], showed no stimulus-related positive signal curves. Furthermore, the signal time course of the cerebellar signal can be used as an independent surrogate parameter for arterial CO2 fluctuations, which serves to confirm physiological hemodynamic response (i.e., sufficient vasodilation after breath hold) [13, 28], including patient compliance with the breath-hold maneuvers.
Relative signal change was then calculated for each time point. Mean relative signal was calculated for the time period of positive flow response to the breath-hold maneuver and displayed in transversal sections covering all supratentorial and infratentorial structures. Random activation of physiological resting state networks may explain regional alterations of the BOLD signal. To calculate significant differences in cerebrovascular reactivity in comparison to the normal population, breath-hold fMRIs of 16 healthy volunteers were analyzed. This reference cohort had no contraindications to fMRI and no clinically significant medical conditions. The relative flow change of each VOI of the atlas was then calculated compared to the flow change of the whole brain by calculating ratios between local and global signal changes. This resulted in an atlas of normal cerebral reactivity. Consequently, the mean relative flow change of every VOI of each patient was tested against the healthy control group using Student’s independent t‑test (p < 0.001). The areas with significant impairment of cerebrovascular reactivity were compared to the clinical hypothesis. The neuroradiologist was blinded to all electroclinical data and was not provided with a localization hypothesis.

Concordance

Concordance between the electroclinical localization hypothesis and the results of breath-hold fMRI was defined as such: i) full concordance corresponded to correct lobar localization and lateralization; ii) partial concordance corresponded to correct lateralization; iii) discordance corresponded to incorrect localization and lateralization. We note that it is currently unclear if breath-hold fMRI offers sufficient spatial resolution to consistently enable sublobar localization. Instead, we chose the broader concepts of lobar localization and lateralization as our endpoints, as they are of key importance in the presurgical evaluation of epilepsy and represent information with an immediate impact on surgical decision-making and a strong correlation to postoperative outcome [2932]. This study was designed as a proof-of-concept study to establish the feasibility and safety of this novel method and was therefore not sufficiently powered for statistical analysis. Cohort size was restricted to 10 participants by the local ethics committee.

Results

We recruited 10 participants with drug-resistant focal epilepsy syndromes. Of these, 7/10 participants presented with temporal lobe epilepsy, which represents two thirds of focal epilepsy syndromes that are assessed in tertiary epilepsy centers [33]. Seizure severity was generally high, with a mean seizure frequency of 49.6 per month (range 0.1–300, SD 87.2) and treatment failure with an average of 5.4 previous and current ASMs (range 2–10, SD 2.8). Complete electroclinical data of phase I presurgical evaluation, including seizure semiology and ictal scalp video EEG monitoring as well as neuropsychological examination results were available for all participants. Interictal and ictal EEG recordings for each participant are shown in the Supplementary Information. Other ancillary testing included magnetoencephalography (n = 3), PET (n = 6), and stereo encephalography (n = 3).
The acquisition of bh-fMRI was feasible in 9/10 cases. One participant with left temporal lobe epilepsy was unable to comply with the breathing maneuvers and was excluded from further analysis after inspection of the signal response curve demonstrated poor data quality. We observed no adverse events, and none of the participants reported any discomfort related to intermittent hypercapnia. All participants, except for participant 6, did not have a seizure for 24 h before bh-fMRI acquisition. Exemplary results of bh-fMRI are shown as normalized cerebrovascular reactivity (CVR) maps in Fig. 1. Fig. 1a demonstrates a focal absence of relative signal increase after breath-hold maneuvers, which corresponds to an impaired CVR (red) in the left temporal region (arrow). This is consistent with the irritative zone and seizure-onset zone of participant 8. Fig. 1b demonstrates impaired CVR primarily in the right temporal region (red, straight arrow) and secondarily in the right temporo-occipital region (light green, curved arrow) which is likewise consistent with the irritative zone and seizure onset zone of participant 6. We found the cerebellar reference signal to be reproducible across the seven breath-hold periods (Fig. 2a), with an average Pearson’s correlation coefficient of 0.814. Likewise, quantitative BOLD measurements were consistent across volumes-of-interest and highlighted regions of impaired stimulus-related signal increase, e.g., in the left superior temporal regions of participant 1 (Fig. 2b). The electroclinical features, epileptogenic zone localization hypothesis, and results of bh-fMRI for all cases are summarized in Table 1.
Table 1
Medical history, electroclinical features and diagnostic findings of the study cohort
Participant ID
1
2
3
4
5
6
7
8
9
10
Sex, age (years)
F, 41
F, 64
F, 29
M, 62
F, 41
F, 21
M, 18
M, 24
F, 22
M, 51
Epilepsy syndrome
TLE
TLE
TLE
TLE
FE
FE
TLE
TLE
FE
TLE
Age at seizure onset (years)
27
39
27
45
6
8
13
12
15
47
Seizure type
FAS, FIAS
FIAS, BTCS
FAS, FIAS, BTCS
FIAS, BTCS
FIAS, BTCS
FAS
FAS, FIAS, BTCS
FIAS
FIAS, BTCS
FAS, FIAS, BTCS
Semiology1
Speech arrest, oral automatisms, postictal aphasia, ATLP
Nonlocalizing
Speech arrest, oral automatisms, postictal aphasia, ATLP
Oral automatisms
Right-side hyperkinetic movement, painful orofacial sensation, salivation
Nonlocalizing
Fear, tachycardia
Nonlocalizing
Right-side facial clonic and head version, postictal aphasia
Speech arrest, manual automatisms
Seizure frequency2
14/month
3/day
6/month
20/month
39/month
300/month
20/month
1/year
4/month
3/month
ASM, previous
LCM, LEV, LTG, PER
LCM, LTG, PER
LEV
LCM, LEV, LTG, ESL, PHT, TPM, VPA
CBZ, LCM, LEV, LTG, PER, PHT, PRM, VPA
LEV, OXC
BRV, LCM, LEV, OXC
OXC
BRV, LCM, LEV, LTG, ESL, OXC, PER, TPM, ZNS
LEV, PER
ASM, current
CNB, ESL
LTG, PRM
LTG
CNB
BRV, TPM
LEV, LTG
LCM, VPA
LTG, VPA
CNB, PER
LCM, PER
Non-medical treatment
None
None
None
None
KD
None
None
None
None
None
vEEG
Left temporal
Right temporal
Left temporal
Left hippocampal
Left posterior insula
Right temporo-occipital
Right temporal
Left temporal
Left insula
Left temporal
MEG
Left temporal and frontobasal
n. d.
n. d.
n. d.
Left posterior insula, left centroparietal region
n. d.
Right frontotemporal
n. d.
n. d.
n. d.
MRI
Nonlesional
Nonlesional
Nonlesional
Nonlesional
Nonlesional; VBM: left insula, left lateral temporal lobe
Nonlesional
Nonlesional
Nonlesional
Nonlesional
Nonlesional
PET
Left temporal
n. d.
Nonlesional
n. d.
Nonlesional
n. d.
Right temporal
n. d.
Nonlesional
Nonlesional
Neuropsychology3
Normal
Right temporal
Impaired figural long-term memory
Left temporal
Non-lateralized frontotemporal dysfunction
Normal
Normal
Left hemisphere
Mild executive deficit
Left frontotemporal
Localization hypothesis
Left temporal
Right temporal
Left temporal
Left hippocampal
Left posterior insula
Right temporo-occipital
Right temporal
Left temporal
Left insula
Left temporal
bh-fMRI
Left temporal
Right and left temporal
Excluded
Diffuse bihemispheric
Left insula, left mesial temporal
Right temporo-occipital
Right temporal, right frontolateral
Left temporal
Left temporal, left frontal
Right temporal
Concordance4
++
0
++
++
++
++
+
ATLP asymmetric tonic limb posturing, ASM antiseizure medication, BTCS focal to bilateral tonic-clonic seizure, FAS focal-aware seizure, FE focal epilepsy, other than temporal lobe epilepsy, FIAS focal impaired awareness seizure, MEG magnetoencephalography, n.d. not done, TLE temporal lobe epilepsy, VBM voxel-based morphometry, vEEG video EEG monitoring. Antiseizure medication abbreviations: BRV brivaracetam, CBZ carbamazepine, CNB cenobamate, ESL eslicarbazepine, KD ketogenic diet, LTG lamotrigine, LEV levetiracetam, LCM lacosamide, OXC oxcarbazepine, PER perampanel, PHT phenytoin, PRM primidone, TPM topiramate, VPA valproate, ZNS zonisamide
1Lateralizing or localizing clinical signs only, not in order of evolution
2Average seizure frequency at time of MRI acquisition
3Abbreviated to lateralization or localization of dysfunction
4++ full concordance, + partial concordance, − discordance, 0 excluded from analysis
Confirmed by stereo electroencephalography
In 6/9 cases, bh-fMRI showed full or partial concordance to the localization hypothesis. In two cases with left and right temporal lobe epilepsy, respectively, bh-fMRI was concordant with FDG-PET (Fig. 3). In a further two cases with left insular epilepsy (participants 5 and 9), bh-fMRI outperformed FDG-PET, which did not yield evidence of focal hypometabolism in both cases. The bh-fMRI mismatches were correctly localized to the temporal lobe, but with contralateral or bilateral lateralization (participants 2, 10). However, bh-fMRI also appropriately identified focal abnormalities in an individual with extratemporal lobe epilepsy (participant 6). In participant 4, the impairment of cerebrovascular reactivity was found to be diffusely distributed across both hemispheres.
The median length of follow-up was 329.5 days (Interquartile range, IQR, 295.5). Two participants were lost to follow-up. Participant 7 had received a hippocampus-sparing resection in the right temporal lobe without an appreciable change in seizure frequency. Of the participants 2 (1, 2) did not proceed to surgery due to later evidence suggesting bilateral seizure onset, 3 participants (3, 6, 10) achieved seizure-freedom with medical treatment and did not proceed to surgery and 2 participants (4, 8) are currently undergoing phase II evaluation. Finally, 2 participants (5, 9) were offered resective surgery but declined.

Discussion

In this prospective single-center single-blind pilot study, bh-fMRI in patients with drug-resistant nonlesional focal epilepsy undergoing presurgical evaluation was feasible and safe. This preliminary study was not designed to establish diagnostic efficacy or clinical utility. However, we note a promising degree of agreement between the electroclinical hypothesis and bh-fMRI results in 6/9 participants. This concordance between different diagnostic modalities has previously been demonstrated to be associated with an improved surgical outcome after FDG-PET, SPECT, SPECT-MRI (SISCOM), ASL, MEG, high-density EEG, sEEG, among others [12, 3439]. This method of multimodal integration and co-registration has become a central aspect and institutional standard for the clinical workflow of individuals with epilepsy undergoing presurgical evaluation [40]. Due to its ease of use and implementation, bh-fMRI may represent a promising adjunct modality among these multimodal neuroimaging studies.
Prior to this study, safety concerns included the use of breathing maneuvers in individuals with epilepsy. Hyperventilation is a common and safe activation procedure used during electroencephalography to increase the diagnostic yield of the method [41]. Conversely, bh-fMRI requires short periods of hypoventilation instead. In the context of sudden unexpected death in epilepsy (SUDEP), Sainju et al. measured the hypercapnic ventilatory response by modified rebreathing in 68 individuals with epilepsy [42]. This test comprised a more severe hypercapnic stimulus than the breath-hold maneuvers in this study but was still found to be safe and well tolerated. More recently, Hampson et al. investigated fMRI BOLD activation in 10 individuals with epilepsy and found differences in brainstem hypercapnia response compared to controls, which may represent a potential imaging biomarker for SUDEP. Their vasoactive stimulus was applied by a computer controlled gas delivery system for carbon dioxide (pCO2 < 50 mm Hg, iso-oxygenation at 110 mm Hg), not breath-hold maneuvers as in our study, and was found to be safe and well tolerated [43]. Likewise, none of our participants experienced discomfort or seizures during bh-fMRI.
Importantly, the precise mechanism by which focal abnormalities seen on bh-fMRI are generated remains unclear, and the relative contribution of regional neuronal damage, altered interictal neuronal centrality, subclinical epileptic activity with increased activity of GABAergic interneurons, and antiseizure medication is unknown. The participants in this study had drug-resistant epilepsy and therefore received many different ASMs. This is a common limitation of fMRI studies in presurgery patients [44]. Each ASM may have a different impact on functional connectivity depending on the cumulative dose, putative mechanism of action, and polytherapy [4548]. These studies were done in cognitive networks, where the impact of ASMs is directly associated with their cognitive side effects (e.g., topiramate). It is unclear if the same concerns apply to bh-fMRI, which is instead based on cerebrovascular reactivity, but this nonetheless limits the generalizability of our findings. Furthermore, we note that we attempted to control for latent epileptic activity by analyzing participants in the interictal period, with at least 24 h since the last seizure. We acknowledge that this may be an overly simplified approach, as the effect of epileptic activity on bh-fMRI is unclear. Lastly, as the underlying mechanism of bh-fMRI is unknown, the histopathological correlate and thus the postoperative seizure outcome associated with the focal and regional abnormalities of cerebrovascular reactivity likewise remain unclear. Thus, further work is required to establish the diagnostic efficacy, concordance with other modalities, clinical utility, and impact on presurgical decision making in a larger cohort.

Funding

The authors did not receive support from any organization for the submitted work.

Declarations

Conflict of interest

C.M. Boßelmann, J. Kegele, L. Zerweck, U. Klose, S. Ethofer, C. Roder, A.M. Grimm and T.-K. Hauser declare that they have no competing interests.

Ethical standards

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the local ethics committee (Medical Faculty, University of Tübingen, IRB-ID 904/2020BO1). Informed consent was obtained from all individual participants included in the study. The authors affirm that human research participants provided informed consent for publication of the images in Fig. 1.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Neurologie & Psychiatrie

Kombi-Abonnement

Mit e.Med Neurologie & Psychiatrie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

e.Med Neurologie

Kombi-Abonnement

Mit e.Med Neurologie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes, den Premium-Inhalten der neurologischen Fachzeitschriften, inklusive einer gedruckten Neurologie-Zeitschrift Ihrer Wahl.

Weitere Produktempfehlungen anzeigen
Literatur
1.
Zurück zum Zitat Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51:1069–77.PubMedCrossRef Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51:1069–77.PubMedCrossRef
2.
Zurück zum Zitat Chen Z, Brodie MJ, Liew D, Kwan P. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study. JAMA Neurol. 2018;75:279–86.PubMedCrossRef Chen Z, Brodie MJ, Liew D, Kwan P. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study. JAMA Neurol. 2018;75:279–86.PubMedCrossRef
3.
Zurück zum Zitat Tellez-Zenteno JF, Patten SB, Jetté N, Williams J, Wiebe S. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia. 2007;48:2336–44.PubMedCrossRef Tellez-Zenteno JF, Patten SB, Jetté N, Williams J, Wiebe S. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia. 2007;48:2336–44.PubMedCrossRef
4.
Zurück zum Zitat Téllez-Zenteno JF, Matijevic S, Wiebe S. Somatic comorbidity of epilepsy in the general population in Canada. Epilepsia. 2005;46:1955–62.PubMedCrossRef Téllez-Zenteno JF, Matijevic S, Wiebe S. Somatic comorbidity of epilepsy in the general population in Canada. Epilepsia. 2005;46:1955–62.PubMedCrossRef
5.
Zurück zum Zitat Kaur J, Paul BS, Goel P, Singh G. Educational achievement, employment, marriage, and driving in adults with childhood-onset epilepsy. Epilepsy Behav. 2019;97:149–53.PubMedCrossRef Kaur J, Paul BS, Goel P, Singh G. Educational achievement, employment, marriage, and driving in adults with childhood-onset epilepsy. Epilepsy Behav. 2019;97:149–53.PubMedCrossRef
6.
Zurück zum Zitat Engel J, McDermott MP, Wiebe S, Langfitt JT, Stern JM, Dewar S, et al. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA. 2012;307:922–30.PubMedPubMedCentralCrossRef Engel J, McDermott MP, Wiebe S, Langfitt JT, Stern JM, Dewar S, et al. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA. 2012;307:922–30.PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Wiebe S, Blume WT, Girvin JP, Eliasziw M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345:311–8.PubMedCrossRef Wiebe S, Blume WT, Girvin JP, Eliasziw M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345:311–8.PubMedCrossRef
8.
Zurück zum Zitat Jones AL, Cascino GD. Evidence on use of neuroimaging for surgical treatment of temporal lobe epilepsy: a systematic review. JAMA Neurol. 2016;73:464–70.PubMedCrossRef Jones AL, Cascino GD. Evidence on use of neuroimaging for surgical treatment of temporal lobe epilepsy: a systematic review. JAMA Neurol. 2016;73:464–70.PubMedCrossRef
9.
Zurück zum Zitat Bernasconi A, Cendes F, Theodore WH, Gill RS, Koepp MJ, Hogan RE, et al. Recommendations for the use of structural magnetic resonance imaging in the care of patients with epilepsy: a consensus report from the International League Against Epilepsy Neuroimaging Task Force. Epilepsia. 2019;60:1054–68.PubMedCrossRef Bernasconi A, Cendes F, Theodore WH, Gill RS, Koepp MJ, Hogan RE, et al. Recommendations for the use of structural magnetic resonance imaging in the care of patients with epilepsy: a consensus report from the International League Against Epilepsy Neuroimaging Task Force. Epilepsia. 2019;60:1054–68.PubMedCrossRef
10.
Zurück zum Zitat Wang I, Bernasconi A, Bernhardt B, Blumenfeld H, Cendes F, Chinvarun Y, et al. MRI essentials in epileptology: a review from the ILAE Imaging Taskforce. Epileptic Disord. 2020;22:421–37.PubMedCrossRef Wang I, Bernasconi A, Bernhardt B, Blumenfeld H, Cendes F, Chinvarun Y, et al. MRI essentials in epileptology: a review from the ILAE Imaging Taskforce. Epileptic Disord. 2020;22:421–37.PubMedCrossRef
11.
Zurück zum Zitat Muhlhofer W, Tan Y‑L, Mueller SG, Knowlton R. MRI-negative temporal lobe epilepsy-What do we know? Epilepsia. 2017;58:727–42.PubMedCrossRef Muhlhofer W, Tan Y‑L, Mueller SG, Knowlton R. MRI-negative temporal lobe epilepsy-What do we know? Epilepsia. 2017;58:727–42.PubMedCrossRef
12.
Zurück zum Zitat Duncan JS, Trimmel K. Advanced neuroimaging techniques in epilepsy. Curr Opin Neurol. 2022;35:189–95.PubMedCrossRef Duncan JS, Trimmel K. Advanced neuroimaging techniques in epilepsy. Curr Opin Neurol. 2022;35:189–95.PubMedCrossRef
13.
Zurück zum Zitat Hauser T‑K, Seeger A, Bender B, Klose U, Thurow J, Ernemann U, et al. Hypercapnic BOLD MRI compared to H215O PET/CT for the hemodynamic evaluation of patients with Moyamoya Disease. Neuroimage Clin. 2019;22:101713.PubMedPubMedCentralCrossRef Hauser T‑K, Seeger A, Bender B, Klose U, Thurow J, Ernemann U, et al. Hypercapnic BOLD MRI compared to H215O PET/CT for the hemodynamic evaluation of patients with Moyamoya Disease. Neuroimage Clin. 2019;22:101713.PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Roder C, Klose U, Hurth H, Brendle C, Tatagiba M, Ernemann U, et al. Longitudinal reproducibility of CO2-triggered BOLD MRI for the hemodynamic evaluation of adult patients with Moyamoya Angiopathy. Cerebrovasc Dis. 2021;50:332–8.PubMedCrossRef Roder C, Klose U, Hurth H, Brendle C, Tatagiba M, Ernemann U, et al. Longitudinal reproducibility of CO2-triggered BOLD MRI for the hemodynamic evaluation of adult patients with Moyamoya Angiopathy. Cerebrovasc Dis. 2021;50:332–8.PubMedCrossRef
15.
Zurück zum Zitat Zerweck L, Roder C, Hauser T‑K, Thurow J, Mengel A, Tatagiba M, et al. Hemodynamic evaluation of patients with Moyamoya Angiopathy: comparison of resting-state fMRI to breath-hold fMRI and [15O]water PET. Neuroradiology. 2022;64:553–63.PubMedCrossRef Zerweck L, Roder C, Hauser T‑K, Thurow J, Mengel A, Tatagiba M, et al. Hemodynamic evaluation of patients with Moyamoya Angiopathy: comparison of resting-state fMRI to breath-hold fMRI and [15O]water PET. Neuroradiology. 2022;64:553–63.PubMedCrossRef
16.
Zurück zum Zitat Bek S, Kaşikçi T, Koç G, Genç G, Demirkaya S, Gökçil Z, et al. Cerebral vasomotor reactivity in epilepsy patients. J Neurol. 2010;257:833–8.PubMedCrossRef Bek S, Kaşikçi T, Koç G, Genç G, Demirkaya S, Gökçil Z, et al. Cerebral vasomotor reactivity in epilepsy patients. J Neurol. 2010;257:833–8.PubMedCrossRef
17.
Zurück zum Zitat Chen S‑F, Pan H‑Y, Huang C‑R, Huang J‑B, Tan T‑Y, Chen N‑C, et al. Autonomic dysfunction contributes to impairment of cerebral autoregulation in patients with epilepsy. J Pers Med. 2021;11:313.PubMedPubMedCentralCrossRef Chen S‑F, Pan H‑Y, Huang C‑R, Huang J‑B, Tan T‑Y, Chen N‑C, et al. Autonomic dysfunction contributes to impairment of cerebral autoregulation in patients with epilepsy. J Pers Med. 2021;11:313.PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Dono F, Evangelista G, Frazzini V, Vollono C, Carrarini C, Russo M, et al. Interictal heart rate variability analysis reveals lateralization of cardiac autonomic control in temporal lobe epilepsy. Front Neurol. 2020;11:842.PubMedPubMedCentralCrossRef Dono F, Evangelista G, Frazzini V, Vollono C, Carrarini C, Russo M, et al. Interictal heart rate variability analysis reveals lateralization of cardiac autonomic control in temporal lobe epilepsy. Front Neurol. 2020;11:842.PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Kalamangalam GP, Nelson JT, Ellmore TM, Narayana PA. Oxygen-enhanced MRI in temporal lobe epilepsy: diagnosis and lateralization. Epilepsy Res. 2012;98:50–61.PubMedCrossRef Kalamangalam GP, Nelson JT, Ellmore TM, Narayana PA. Oxygen-enhanced MRI in temporal lobe epilepsy: diagnosis and lateralization. Epilepsy Res. 2012;98:50–61.PubMedCrossRef
20.
Zurück zum Zitat O’Brien TJ, David EP, Kilpatrick CJ, Desmond P, Tress B. Contrast-enhanced perfusion and diffusion MRI accurately lateralize temporal lobe epilepsy: a pilot study. J Clin Neurosci. 2007;14:841–9.PubMedCrossRef O’Brien TJ, David EP, Kilpatrick CJ, Desmond P, Tress B. Contrast-enhanced perfusion and diffusion MRI accurately lateralize temporal lobe epilepsy: a pilot study. J Clin Neurosci. 2007;14:841–9.PubMedCrossRef
21.
Zurück zum Zitat Lim Y‑M, Cho Y‑W, Shamim S, Solomon J, Birn R, Luh WM, et al. Usefulness of pulsed arterial spin labeling MR imaging in mesial temporal lobe epilepsy. Epilepsy Res. 2008;82:183–9.PubMedPubMedCentralCrossRef Lim Y‑M, Cho Y‑W, Shamim S, Solomon J, Birn R, Luh WM, et al. Usefulness of pulsed arterial spin labeling MR imaging in mesial temporal lobe epilepsy. Epilepsy Res. 2008;82:183–9.PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Pendse N, Wissmeyer M, Altrichter S, Vargas M, Delavelle J, Viallon M, et al. Interictal arterial spin-labeling MRI perfusion in intractable epilepsy. J Neuroradiol. 2010;37:60–3.PubMedCrossRef Pendse N, Wissmeyer M, Altrichter S, Vargas M, Delavelle J, Viallon M, et al. Interictal arterial spin-labeling MRI perfusion in intractable epilepsy. J Neuroradiol. 2010;37:60–3.PubMedCrossRef
23.
Zurück zum Zitat Inoue Y, Tanaka Y, Hata H, Hara T. Arterial spin-labeling evaluation of cerebrovascular reactivity to acetazolamide in healthy subjects. AJNR Am J Neuroradiol. 2014;35:1111–6.PubMedPubMedCentralCrossRef Inoue Y, Tanaka Y, Hata H, Hara T. Arterial spin-labeling evaluation of cerebrovascular reactivity to acetazolamide in healthy subjects. AJNR Am J Neuroradiol. 2014;35:1111–6.PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Luders H. General principles. Surgical treatment of the epilepsies. 1993. pp. 137–53. Luders H. General principles. Surgical treatment of the epilepsies. 1993. pp. 137–53.
25.
Zurück zum Zitat Lüders HO, Najm I, Nair D, Widdess-Walsh P, Bingman W. The epileptogenic zone: general principles. Epileptic Disord. 2006;8(Suppl 2):S1–9.PubMed Lüders HO, Najm I, Nair D, Widdess-Walsh P, Bingman W. The epileptogenic zone: general principles. Epileptic Disord. 2006;8(Suppl 2):S1–9.PubMed
26.
Zurück zum Zitat Kahane P, Landré E, Minotti L, Francione S, Ryvlin P. The Bancaud and Talairach view on the epileptogenic zone: a working hypothesis. Epileptic Disord. 2006;8(Suppl 2):S16–26.PubMed Kahane P, Landré E, Minotti L, Francione S, Ryvlin P. The Bancaud and Talairach view on the epileptogenic zone: a working hypothesis. Epileptic Disord. 2006;8(Suppl 2):S16–26.PubMed
27.
Zurück zum Zitat Rolls ET, Huang C‑C, Lin C‑P, Feng J, Joliot M. Automated anatomical labelling atlas 3. Neuroimage. 2020;206:116189.PubMedCrossRef Rolls ET, Huang C‑C, Lin C‑P, Feng J, Joliot M. Automated anatomical labelling atlas 3. Neuroimage. 2020;206:116189.PubMedCrossRef
28.
Zurück zum Zitat Dlamini N, Shah-Basak P, Leung J, Kirkham F, Shroff M, Kassner A, et al. Breath-hold blood oxygen level-dependent MRI: a tool for the assessment of cerebrovascular reserve in children with Moyamoya disease. AJNR Am J Neuroradiol. 2018;39:1717–23.PubMedPubMedCentralCrossRef Dlamini N, Shah-Basak P, Leung J, Kirkham F, Shroff M, Kassner A, et al. Breath-hold blood oxygen level-dependent MRI: a tool for the assessment of cerebrovascular reserve in children with Moyamoya disease. AJNR Am J Neuroradiol. 2018;39:1717–23.PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Janszky J, Pannek HW, Fogarasi A, Bone B, Schulz R, Behne F, et al. Prognostic factors for surgery of neocortical temporal lobe epilepsy. Seizure. 2006;15:125–32.PubMedCrossRef Janszky J, Pannek HW, Fogarasi A, Bone B, Schulz R, Behne F, et al. Prognostic factors for surgery of neocortical temporal lobe epilepsy. Seizure. 2006;15:125–32.PubMedCrossRef
30.
Zurück zum Zitat Carrette E, Vonck K, De Herdt V, Van Dycke A, El Tahry R, Meurs A, et al. Predictive factors for outcome of invasive video-EEG monitoring and subsequent resective surgery in patients with refractory epilepsy. Clin Neurol Neurosurg. 2010;112:118–26.PubMedCrossRef Carrette E, Vonck K, De Herdt V, Van Dycke A, El Tahry R, Meurs A, et al. Predictive factors for outcome of invasive video-EEG monitoring and subsequent resective surgery in patients with refractory epilepsy. Clin Neurol Neurosurg. 2010;112:118–26.PubMedCrossRef
31.
Zurück zum Zitat Jayakar P, Gaillard WD, Tripathi M, Libenson MH, Mathern GW, Cross JH, et al. Diagnostic test utilization in evaluation for resective epilepsy surgery in children. Epilepsia. 2014;55:507–18.PubMedCrossRef Jayakar P, Gaillard WD, Tripathi M, Libenson MH, Mathern GW, Cross JH, et al. Diagnostic test utilization in evaluation for resective epilepsy surgery in children. Epilepsia. 2014;55:507–18.PubMedCrossRef
32.
Zurück zum Zitat Elwan S, Alexopoulos A, Silveira DC, Kotagal P. Lateralizing and localizing value of seizure semiology: comparison with scalp EEG, MRI and PET in patients successfully treated with resective epilepsy surgery. Seizure. 2018;61:203–8.PubMedCrossRef Elwan S, Alexopoulos A, Silveira DC, Kotagal P. Lateralizing and localizing value of seizure semiology: comparison with scalp EEG, MRI and PET in patients successfully treated with resective epilepsy surgery. Seizure. 2018;61:203–8.PubMedCrossRef
33.
Zurück zum Zitat Téllez-Zenteno JF, Hernández-Ronquillo L. A review of the epidemiology of temporal lobe epilepsy. Epilepsy Res Treat. 2012;2012:630853.PubMed Téllez-Zenteno JF, Hernández-Ronquillo L. A review of the epidemiology of temporal lobe epilepsy. Epilepsy Res Treat. 2012;2012:630853.PubMed
34.
Zurück zum Zitat Seo JH, Holland K, Rose D, Rozhkov L, Fujiwara H, Byars A, et al. Multimodality imaging in the surgical treatment of children with nonlesional epilepsy. Neurology. 2011;76:41–8.PubMedPubMedCentralCrossRef Seo JH, Holland K, Rose D, Rozhkov L, Fujiwara H, Byars A, et al. Multimodality imaging in the surgical treatment of children with nonlesional epilepsy. Neurology. 2011;76:41–8.PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Nowell M, Rodionov R, Zombori G, Sparks R, Winston G, Kinghorn J, et al. Utility of 3D multimodality imaging in the implantation of intracranial electrodes in epilepsy. Epilepsia. 2015;56:403–13.PubMedPubMedCentralCrossRef Nowell M, Rodionov R, Zombori G, Sparks R, Winston G, Kinghorn J, et al. Utility of 3D multimodality imaging in the implantation of intracranial electrodes in epilepsy. Epilepsia. 2015;56:403–13.PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat Murphy MA, O’Brien TJ, Morris K, Cook MJ. Multimodality image-guided surgery for the treatment of medically refractory epilepsy. J Neurosurg. 2004;100:452–62.PubMedCrossRef Murphy MA, O’Brien TJ, Morris K, Cook MJ. Multimodality image-guided surgery for the treatment of medically refractory epilepsy. J Neurosurg. 2004;100:452–62.PubMedCrossRef
37.
Zurück zum Zitat Hogan RE, Lowe VJ, Bucholz RD. Triple-technique (MR imaging, single-photon emission CT, and CT) coregistration for image-guided surgical evaluation of patients with intractable epilepsy. Ajnr Am J Neuroradiol. 1999;20:1054–8.PubMedPubMedCentral Hogan RE, Lowe VJ, Bucholz RD. Triple-technique (MR imaging, single-photon emission CT, and CT) coregistration for image-guided surgical evaluation of patients with intractable epilepsy. Ajnr Am J Neuroradiol. 1999;20:1054–8.PubMedPubMedCentral
38.
Zurück zum Zitat Říha P, Doležalová I, Mareček R, Lamoš M, Bartoňová M, Kojan M, et al. Multimodal combination of neuroimaging methods for localizing the epileptogenic zone in MR-negative epilepsy. Sci Rep. 2022;12:15158.PubMedPubMedCentralCrossRef Říha P, Doležalová I, Mareček R, Lamoš M, Bartoňová M, Kojan M, et al. Multimodal combination of neuroimaging methods for localizing the epileptogenic zone in MR-negative epilepsy. Sci Rep. 2022;12:15158.PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Vollmar C, Peraud A, Noachtar S. Multimodal imaging in extratemporal epilepsy surgery. Cureus.10:e2338. Vollmar C, Peraud A, Noachtar S. Multimodal imaging in extratemporal epilepsy surgery. Cureus.10:e2338.
41.
Zurück zum Zitat Guaranha MSB, Garzon E, Buchpiguel CA, Tazima S, Yacubian EMT, Sakamoto AC. Hyperventilation revisited: physiological effects and efficacy on focal seizure activation in the era of video-EEG monitoring. Epilepsia. 2005;46:69–75.PubMedCrossRef Guaranha MSB, Garzon E, Buchpiguel CA, Tazima S, Yacubian EMT, Sakamoto AC. Hyperventilation revisited: physiological effects and efficacy on focal seizure activation in the era of video-EEG monitoring. Epilepsia. 2005;46:69–75.PubMedCrossRef
42.
Zurück zum Zitat Sainju RK, Dragon DN, Winnike HB, Nashelsky MB, Granner MA, Gehlbach BK, et al. Ventilatory response to CO2 in patients with epilepsy. Epilepsia. 2019;60:508–17.PubMedPubMedCentralCrossRef Sainju RK, Dragon DN, Winnike HB, Nashelsky MB, Granner MA, Gehlbach BK, et al. Ventilatory response to CO2 in patients with epilepsy. Epilepsia. 2019;60:508–17.PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Hampson JP, Lacuey N, Rani MS, Hampson JS, Simeone KA, Simeone TA, et al. Functional MRI correlates of carbon dioxide chemosensing in persons with epilepsy. Front Neurol. 2022;13:896204.PubMedPubMedCentralCrossRef Hampson JP, Lacuey N, Rani MS, Hampson JS, Simeone KA, Simeone TA, et al. Functional MRI correlates of carbon dioxide chemosensing in persons with epilepsy. Front Neurol. 2022;13:896204.PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Pittau F, Grova C, Moeller F, Dubeau F, Gotman J. Patterns of altered functional connectivity in mesial temporal lobe epilepsy. Epilepsia. 2012;53:1013–23.PubMedPubMedCentralCrossRef Pittau F, Grova C, Moeller F, Dubeau F, Gotman J. Patterns of altered functional connectivity in mesial temporal lobe epilepsy. Epilepsia. 2012;53:1013–23.PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Xiao F, Caciagli L, Wandschneider B, Joshi B, Vos SB, Hill A, et al. Effect of anti-seizure medications on functional anatomy of language: a perspective from language functional magnetic resonance imaging. Front Neurosci. 2022;15:787272.PubMedPubMedCentralCrossRef Xiao F, Caciagli L, Wandschneider B, Joshi B, Vos SB, Hill A, et al. Effect of anti-seizure medications on functional anatomy of language: a perspective from language functional magnetic resonance imaging. Front Neurosci. 2022;15:787272.PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Wandschneider B, Burdett J, Townsend L, Hill A, Thompson PJ, Duncan JS, et al. Effect of topiramate and zonisamide on fMRI cognitive networks. Neurology. 2017;88:1165–71.PubMedPubMedCentralCrossRef Wandschneider B, Burdett J, Townsend L, Hill A, Thompson PJ, Duncan JS, et al. Effect of topiramate and zonisamide on fMRI cognitive networks. Neurology. 2017;88:1165–71.PubMedPubMedCentralCrossRef
47.
Zurück zum Zitat Xiao F, Caciagli L, Wandschneider B, Sander JW, Sidhu M, Winston G, et al. Effects of carbamazepine and lamotrigine on functional magnetic resonance imaging cognitive networks. Epilepsia. 2018;59:1362–71.PubMedPubMedCentralCrossRef Xiao F, Caciagli L, Wandschneider B, Sander JW, Sidhu M, Winston G, et al. Effects of carbamazepine and lamotrigine on functional magnetic resonance imaging cognitive networks. Epilepsia. 2018;59:1362–71.PubMedPubMedCentralCrossRef
48.
Zurück zum Zitat Jokeit H, Okujava M, Woermann FG. Carbamazepine reduces memory induced activation of mesial temporal lobe structures: a pharmacological fMRI-study. BMC Neurol. 2001;1:6.PubMedPubMedCentralCrossRef Jokeit H, Okujava M, Woermann FG. Carbamazepine reduces memory induced activation of mesial temporal lobe structures: a pharmacological fMRI-study. BMC Neurol. 2001;1:6.PubMedPubMedCentralCrossRef
Metadaten
Titel
Breath-Hold-Triggered BOLD fMRI in Drug-Resistant Nonlesional Focal Epilepsy—A Pilot Study
verfasst von
Christian M. Boßelmann
Josua Kegele
Leonie Zerweck
Uwe Klose
Silke Ethofer
Constantin Roder
Alexander M. Grimm
Till-Karsten Hauser
Publikationsdatum
11.12.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Neuroradiology
Print ISSN: 1869-1439
Elektronische ISSN: 1869-1447
DOI
https://doi.org/10.1007/s00062-023-01363-2

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.